Efficacy of epicardially delivered adipose stroma cell sheets in dilated cardiomyopathy

Cardiovascular Research

Volumn 99, Issue 4, 2013, Pages 640-647

  Hamdi, Hadhami ^a   Boitard, Solène Emmanuelle ^b   Planat Benard, Valérie ^a   Pouly, Julia ^c   Neamatalla, Hany ^c   Joanne, Pierre ^b   Perier, Marie Cécile ^d   Bellamy, Valérie ^a   Casteilla, Louis ^a   Li, Zhenlin ^e   Hagège, Albert Alain ^a,c   Mericskay, Mathias ^e   Menasché, Philippe ^a,c   Agbulut, Onnik ^b  

^a INSERM   (France)

^b Groupe Hospitalier Pitié Salpêtrière   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

Cardiomyopathy; Cell therapy; Fibrosis; Remodelling; Stem cells

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BONE MORPHOGENETIC PROTEIN 4; BRAIN NATRIURETIC PEPTIDE; GREEN FLUORESCENT PROTEIN; MYOSIN HEAVY CHAIN BETA; POLYMER; TAMOXIFEN;

ADIPOSE TISSUE CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FATE; CELL TRANSPLANTATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENGRAFTMENT; FIBROSIS; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GENE EXPRESSION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; STROMA CELL; VASCULARIZATION;

CARDIOMYOPATHY; CELL THERAPY; FIBROSIS; REMODELLING; STEM CELLS;

ADIPOSE TISSUE; ANIMALS; CARDIOMYOPATHY, DILATED; FIBROSIS; KI-67 ANTIGEN; MICE; MICE, INBRED C57BL; MYOCARDIUM; PERICARDIUM; STROMAL CELLS; VENTRICULAR REMODELING;

EID: 84883223218     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt149     Document Type: Article

References (32)

1. Hershberger RE, Morales A, Siegfried JD. Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals. Genet Med 2010;12:655-667.
2. Clegg AJ, Scott DA, Loveman E, Colquitt JL, Royle P, Bryant J. Clinical and costeffectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation. Eur Heart J 2006;27:2929-2938.
3. Dow J, Simkhovich BZ, Kedes L, Kloner RA. Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res 2005;67: 301-307.
4. Smets FN, Chen Y, Wang L-J, Soriano HE. Loss of cell anchorage triggers apoptosis (anoikis) in primary mouse hepatocytes. Mol Genet Metab 2002;75:344-352.
5. Hamdi H, Planat-Benard V, Bel A, Puymirat E, Geha R, Pidial L et al. Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. Cardiovasc Res 2011;91:483-491.
6. MiyaharaY, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, HaoHet al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-465.
7. Hamdi H, Furuta A, Bellamy V, Bel A, Puymirat E, Peyrard S et al. Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann Thorac Surg 2009;87:1196-1203.
8. Kawamura M, Miyagawa S, Miki K, Saito A, Fukushima S, Higuchi T et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 2012;126:S29-S37.
9. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004;109:1292-1298.
10. Mazo M, Planat-Bénard V, Abizanda G, Pelacho B, Léobon B, Gavira JJ et al. Transplantation of adipose-derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. Eur J Heart Fail 2008;10:454-462.
11. Valina C, Pinkernell K, Song Y-H, Bai X, Sadat S, Campeau RJ et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 2007;28: 2667-2677.
12. Mazo M, Hernández S, Gavira JJ, Abizanda G, Araña M, López-Mart́nezTet al.Treatment of reperfused ischemia with adipose-derived stem cells in a preclinical swine model of myocardial infarction. Cell transplantation 2012;21:2723-2733.
13. Parlakian A, Charvet C, Escoubet B, Mericskay M, Molkentin JD, Gary-BoboGet al. Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart. Circulation 2005;112:2930-2939.
14. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 1997;407:313-319.
15. Planat-Benard V, Silvestre J-S, Cousin B, André M, NibbelinkM, Tamarat R et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004;109:656-663.
16. Touvron M, Escoubet B, Mericskay M, Angelini A, Lamotte L, Santini MP et al. Locally expressed IGF1 propeptide improvesmouse heart function in induced dilated cardiomyopathy by blocking myocardial fibrosis and SRF-dependent CTGF induction. Dis Model Mech 2012;5:481-491.
17. Suzuki K, Murtuza B, Suzuki N, Smolenski RT,Yacoub MH.Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure. Circulation 2001;104:I213-I217.
18. Pouly J, Hagège AA, Vilquin J-T, Bissery A, Rouche A, Bruneval P et al. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? Circulation 2004;110:1626-1631.
19. Agbulut O, Menot M-L, Li Z, Marotte F, Paulin D, Hagège AA et al. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovasc Res 2003;58:451-459.
20. Chen Y, LiuW, LiW, Gao C. Autologous bone marrow mesenchymal cell transplantation improves left ventricular function in a rabbit model of dilated cardiomyopathy. Exp Mol Pathol 2010;88:311-315.
21. Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu X-K, Miki T et al. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells 2008;26: 2644-2653.
22. Singla DK, Ahmed A, Singla R, Yan B. Embryonic Stem Cells ImproveCardiac Function in Doxorubicin-Induced Cardiomyopathy Mediated through Multiple Mechanisms. Cell Transplant 2012;21:1919-1930.
23. Davis FJ, Gupta M, Pogwizd SM, Bacha E, Jeevanandam V, Gupta MP. Increased expression of alternatively spliced dominant-negative isoform of SRF in human failing hearts. Am J Physiol Heart Circ Physiol 2002;282:H1521-H1533.
24. Chang J,Wei L, Otani T, Youker KA, Entman ML, Schwartz RJ. Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading. Circulation 2003;108:407-413.
25. Parlakian A, Tuil D, Hamard G, Tavernier G, Hentzen D, Concordet J-P et al. Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality. Mol Cell Biol 2004;24:5281-5289.
26. Gary-Bobo G, Parlakian A, Escoubet B, Franco CA, Clément S, Bruneval P et al. Mosaic inactivation of the serum response factor gene in the myocardium induces focal lesions and heart failure. Eur J Heart Fail 2008;10:635-645.
27. Diguet N, Mallat Y, Ladouce R, Clodic G, Prola A, Tritsch E et al. Muscle creatine kinase deficiency triggers both actin depolymerization and desmin disorganization by advanced glycation end products in dilated cardiomyopathy. J Biol Chem 2011;286: 35007-35019.
28. Maltais S, Tremblay JP, Perrault LP, Ly HQ. The paracrine effect: pivotal mechanism in cell-based cardiac repair. J Cardiovasc Transl Res 2010;3:652-662.
29. Okayama K, Azuma J, Dosaka N, Iekushi K, Sanada F, Kusunoki H et al. Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition. Hypertension 2012;59:958-965.
30. Perez-Ilzarbe M, Agbulut O, Pelacho B, Ciorba C, San Jose-Eneriz E, Desnos M et al. Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail 2008;10:1065-1072.
31. Zhang D, Shadrin IY,LamJ, XianHQ,Snodgrass HR, Bursac N. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 2013;34:5813-5820. S0142-9612(13)00470- 5.
32. Kimura T, Miyoshi S, Takatsuki S, Tanimoto K, Fukumoto K, Soejima K et al. Safety and efficacy of pericardial endoscopy by percutaneous subxyphoid approach in swine heart in vivo. J Thorac Cardiovasc Surg 2011;142:181-190.